293480 — Hana Pharm Co Balance Sheet
0.000.00%
- KR₩163bn
- KR₩203bn
- KR₩225bn
Annual balance sheet for Hana Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 56,866 | 17,582 | 3,425 | 8,717 | 10,041 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 42,780 | 44,306 | 46,167 | 43,251 | 45,908 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 140,455 | 103,527 | 102,421 | 105,992 | 117,816 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 122,399 | 151,868 | 157,841 | 186,497 | 208,343 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 303,497 | 345,965 | 348,386 | 382,011 | 418,141 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 40,845 | 44,704 | 56,126 | 31,826 | 64,159 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 51,596 | 77,568 | 70,401 | 72,835 | 104,732 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 251,901 | 268,397 | 277,985 | 309,176 | 313,409 |
| Total Liabilities & Shareholders' Equity | 303,497 | 345,965 | 348,386 | 382,011 | 418,141 |
| Total Common Shares Outstanding |